Cintas Corporation today declared it has focused on fundraising for the American Heart Association.

Cintas commits fundraising for AHA programs to market heart health awareness In recognition of American Center Month, Cintas Corporation today declared it has focused on fundraising for the American Heart Association , as part of its MEDICAL & Safety Division’s efforts to raise awareness about heart health. As the biggest service provider of CPR, AED and medical training produced by the AHA, Cintas is usually applying company-wide initiatives to improve funds surrounding various AHA events, including Go Crimson for Women, Start! and AHA nation-wide heart walks. An average of 2,300 Americans die of coronary disease each day – one death every 38 mere seconds, added Nancy Wolff, Executive Director Dallas Division, American Cardiovascular Association.Ashwagandha may be the super adaptogen Life in the 21st century is certainly full of stress in the form of emotional setbacks, environmental toxins, physical trauma & poor nutrition. This stress depletes the body of critical nutrients and causes oxidation of various cellular elements. Ashwagandha can be an adaptogenic herb that assists the body adapt to stressful conditions successfully. Ashwagandha is called Indian ginseng also, wintertime cherry, & Withania Somnifera. Though it grows in North America and Africa naturally, it is most associated with the Ayurvedic traditions of the east commonly. Ayurveda is an ancient application and philosophy of organic wellness common in India and the Far East.

MEA News & Events

MEA LAUNCHES EXPANSION INTO CHINA'S HEALTHCARE MARKETPLACE

MedEd Architects announced the launch of a series of on-going educational programs specifically targeted to reach as many as 2.6 million Chinese physicians. The series includes live symposia and web-based programs developed in partnership with renowned US -based medical centers and leading Chinese medical societies. Programs will be accessed through a branded web portal designed to generate awareness of new treatment choices among Chinese physicians.